Teams link: Join the meeting now

Meeting ID: 277 080 580 861 9

Passcode: nk3a6S6b


Learning Objectives: 

  • Summarize the evidence that has previously driven guideline recommendations for dual-pathway antithrombotic regimens

  • Apply the findings of the AFIRE and AQUATIC trials to patients with concomitant atrial fibrillation (AF) and stable coronary artery disease (CAD)

  • Evaluate antithrombotic regimens for opportunities to de-escalate

Session date: 
10/23/2025 - 2:00pm to 3:00pm CDT
Location: 
In-person and Virtually
Will be determined by room availability
600 Highland Ave
Madison, WI 53705
United States
  • 1.00 ACPE Contact Hours - Pharmacist
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
Please login or register to take this course.
Discloser List CME Internal Report
Presenter(s): 
Amber Woolley, PharmD